68
InnoCare Pharma Ltd. (688428)
SSE
28.36
-0.45 (-1.56%)
Closed
Sep 18, 2026
Day's Range
28.1029.61
52 wk Range
19.3633.33
Financial Statements - 688428 - InnoCare Pharma Ltd.
Revenue
2.37B▲ 135.3%
Net Income
644.18M▲ 242.2%Net Margin 27.1%
EBITDA
825.50M▲ 365.4%
Free Cash Flow
13.76M▲ 103.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.37B | 1B | 738.53M | 625.40M | 1.04B | 1.36M |
| Cost of Goods | 191.11M | 138.44M | 128.43M | 143.39M | 65.66M | 0 |
| Gross Profit | 2.18B | 871M | 610.10M | 482M | 977.36M | 1.36M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 495.99M | -525.78M | -652.50M | -731.14M | -166.23M | -494.54M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 655.74M | -452.59M | -644.20M | -893.72M | -20.12M | -391.86M |
| Income Tax | 11.55M | 263K | 1.42M | 0 | 46.55M | 0 |
| Net Income | 644.18M | -452.85M | -645.63M | -893.72M | -66.67M | -391.86M |
| EPS Basic | - | -0.26 | -0.37 | -0.6 | -0.05 | -0.404511 |
| EPS Diluted | - | -0.26 | -0.37 | -0.6 | -0.05 | -0.404511 |
| Basic Shares Outstanding | - | 1.69B | 1.68B | 1.47B | 1.36B | 967.57M |
| Diluted Shares Outstanding | - | 1.69B | 1.68B | 1.47B | 1.36B | 967.57M |
| Ebit | 709.87M | -418.80M | -609.13M | -876.68M | -17.47M | -390.72M |
| Ebitda | 825.50M | -311.05M | -505.48M | -814.73M | 9.53M | -379.27M |
| Net Income Continuous Operations | 655.74M | -452.59M | -644.20M | -893.72M | -20.12M | -391.86M |
| Minority Interests | -1.71M | 12.22M | 14.36M | 7.13M | 2.13M | 470K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
